Inergetics Inc (fka NRTI)

[crookedneck]

Great post G&L, you hit the nail on the head. There are plenty of those lurking around to try and bring this down with their fear induced post. Know what you own and ignore these baseless post that are an obvious attempt to push it down with useless banter that is intended to help their only objective of driving it downward. They want to scare folks out ahead of what will be a monumental shift for the company into the CBD field with the only company that will have this kind of support and high quality product!

We are about to enter the fastest growing segment for the next 5 years with a huge competitive advantage and all the top MJ experts in our corner! Connect the dots to see where this headed very shortly. IN less than a few weeks they will be meeting with their Advisory Board to put the final touches on everything and yet these folks want you to sell now? Know what you own. Cheers!

Inergetics' Scientific/Medical Advisory Board to Meet as Company Enters Final Development Phase of New CBD Product Line
Board to Offer Final Review of Product Formulation Prior to Manufacturing and Launch in Medical Marijuana Dispensaries
PR Newswire Inergetics, Inc.
October 21, 2014 9:00 AM
????
NEWARK, N.J., Oct. 21, 2014 /PRNewswire/ -- Inergetics, Inc. (NRTI), a world-class developer of nutritional supplements, today announced that it will convene a meeting of its Scientific/Medical Advisory Board on November 20, 2014 in San Francisco/Oakland, California. The advisory board is responsible for guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements that Inergetics is planning to bring to market next year.

The meeting is being convened by Inergetics' Chief Science Officer, Carl Germano, RD, CNS, CDN, and will feature the five members of the advisory board: Dr. Justin Fischedick, Dr. Joseph McSherry, Dr. Michelle Sexton, Dr. Yu Shao and Dr. Mark Wallace. Additional participants will include Inergetics CEO Mike James and CMO Jim Kras.

"As we enter the third and final phase of product development for our CBD line of nutritional supplements, we wanted to convene our Scientific/Medical Advisory Board for its final review of and recommendation on the product formulation prior to our beginning the manufacturing process," said Carl Germano. "I look forward to a productive meeting as we continue to mark significant progress toward the market launch of our initial phytocannabinoid product in 2015."

During the meeting in California, the Inergetics team will be touring dispensaries and an extraction facility, as well as reviewing the branding, packaging and marketing of the product line. Inergetics previously announced that the initial product in the line will incorporate an important cannabinoid from a novel non-cannabis source. The company expects that the inaugural product's unique combination of cannabinoids will enable it to deliver additional synergistic benefits in terms of overall efficacy and absorption.

"We are very excited to be entering the final stages of product development for our CBD line of nutritional supplements, beginning with our 'first to market' combination cannabinoid product," said Mike James, CEO of Inergetics. "We are confident that our proven expertise in creating, branding and marketing supplements will translate perfectly to our innovative CBD line of products, and that these products will appeal to consumers experiencing various pain-related ailments," James added.

Inergetics will be launching its new CBD product line in medical marijuana dispensaries in 2015.

Continued updates on the CBD product initiative and the Scientific/Medical Advisory Board will be made available at http://www.inergetics.com/cbd-initiative/.